(Q38375838)

English

Bivalirudin vs. unfractionated heparin during percutaneous coronary interventions in patients with stable and unstable angina pectoris: 1-year results of the ISAR-REACT 3 trial

scientific article published on 11 February 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Bivalirudin vs. unfractionated heparin during percutaneous coronary interventions in patients with stable and unstable angina pectoris: 1-year results of the ISAR-REACT 3 trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

unstable angina

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Julinda Mehilli

2

object named as

Julinda Mehilli

0 references

Albert Schömig

9

object named as

Albert Schömig

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

10

object named as

Adnan Kastrati

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Sebastian Kufner

object named as

Sebastian Kufner

6

0 references

Stefanie Schulz

object named as

Stefanie Schulz

1

0 references

Franz-Josef Neumann

4

object named as

Franz-Josef Neumann

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

author name string

Gjin Ndrepepa

3

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Katrin A Birkmeier

5

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Gert Richardt

7

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Peter B Berger

8

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 3 Trial Investigators

11

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

publication date

11 February 2010

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

European Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

582-587

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ008

21 January 2018

Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial)

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ008

21 January 2018

Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ008

21 January 2018

Bivalirudin for patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ008

21 January 2018

Bivalirudin during primary PCI in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ008

21 January 2018

Bivalirudin versus unfractionated heparin during percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ008

21 January 2018

Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ008

21 January 2018

Clinical end points in coronary stent trials: a case for standardized definitions

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ008

21 January 2018

Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ008

21 January 2018

Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ008

21 January 2018

A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ008

21 January 2018

Profile of bleeding and ischaemic complications with bivalirudin and unfractionated heparin after percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ008

21 January 2018

Bivalirudin decreases NO bioavailability by vascular immobilization of myeloperoxidase

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ008

21 January 2018

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ008

21 January 2018

Onset and offset of platelet inhibition after high-dose clopidogrel loading and standard daily therapy measured by a point-of-care assay in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ008

21 January 2018

Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Ef

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ008

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ008

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHQ008

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38375838&oldid=1756612799"